# Amsino acquires MedXL to expand North American manufacturing

Amsino International has acquired the assets of MedXL, including manufacturing facilities in Montreal, Canada, adding two FDA- and Health Canada-registered facilities and a distribution center. The acquisition doubles Amsino's syringe production capacity to over 500 million units annually.

- Type: Acquisition
- Announced: 2024-11-26
- Where: Montreal, Quebec, Canada
- Status: completed
- Capacity: 500 million units per year
- Products: prefilled syringes, drug delivery devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [MedXL](https://endata.com/companies/63560.md) (target)
- [Amsino International](https://endata.com/companies/81313.md) (acquirer)

## Sources

- [g-medtech.com](https://g-medtech.com/news/amsino-acquires-medxl-to-expand-north-american-manufacturing-and-double-syringe-production-capacity/), 2024-11-26: "This acquisition aligns with our strategy to strengthen North American manufacturing and improve supply chain resilience in today's complex geopolitical climate."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.